BE AWARE OF IMPERSONATION SCAMS: Board staff will not contact you by telephone and demand payment of funds for any reason.
The Board of Pharmacy office will be closed on Monday, May 25 in observance of Memorial Day.
An official website of the State of Louisiana.
BE AWARE OF IMPERSONATION SCAMS: Board staff will not contact you by telephone and demand payment of funds for any reason.
The Board of Pharmacy office will be closed on Monday, May 25 in observance of Memorial Day.
Every person who conducts research with, manufactures, distributes, procures, possesses, prescribes, or dispenses any controlled dangerous substance within this state, including third-party logistics providers, or who proposes to engage in the research, manufacture, distribution, procurement, possession, prescribing, or dispensing of any controlled dangerous substance within this state shall obtain a controlled dangerous substance (CDS) license from the board prior to engaging in such activities. Only persons actually engaged in such activities are required to obtain a CDS license; related or affiliated persons, e.g., stockholder in manufacturing corporation, who are not engaged in such activities, are not required to be licensed. The performance of such activities in the absence of a valid CDS license shall be a violation of R.S. 40:973.
Fee: $30.00
Application: Application for New Louisiana Controlled Dangerous Substance (CDS) License for Researcher. This application is available in electronic format online through the Online Services Portal.
Required Attachments (Checklist):
Criminal Background Check: The board will supply the applicant with information necessary to perform a criminal background check (CBC) with the Louisiana State Police (LSP) and the Federal Bureau of Investigation (FBI). The CBC will be waived for applicants that have previously completed the requirement through this agency or who have a professional healthcare license issued by another Louisiana agency.
Criminal history may be used as a basis for denial. All factors outlined in LA:R.S. 37:2950 shall be considered.
Board Review: A review of prior actions and criminal history is completed when all documents have been received and payment processed.
Inspection: In the event that there are no matters preventing the issuance, the applicant shall be instructed to contact the pharmacist compliance officer for that part of the state to arrange a site inspection at a mutually agreeable time.
Issuance: When the compliance officer has verified compliance with the minimum standards, the license will be issued.
Start the application process.
Inquiries regarding the Controlled Dangerous Substance License may be submitted to:
Ashley Moses, Licensing Analyst - Amoses@pharmacy.la.gov